 |
Trials |
A randomised Phase II study of MK-3475 versus Chemotherapy in Pateients with Advanced MelanomaCancer type: Melanoma Phase: II Principal Investigator: Nyakas Martha Country: NO Keywords: Norway, Oslo, Jelanoma, MSD, MK-3475-002 Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01704287?term=MK-3475-002&rank=1 |